Strength
.5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762100501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
CABERGOLINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020664On Market Since
9/22/2014
Pharmacological Classes
Ergolines
Ergot Derivative
Related Drugs
Same classification
CABERGOLINE 0.5 MG TABLET
Generic
00093542088•Teva Pharmaceuticals USA Inc.
$1.4361
per EA
CABERGOLINE 0.5 MG TABLET
Generic
23155082373•Heritage Pharmaceuticals Inc.
$1.4361
per EA
CABERGOLINE 0.5 MG TABLET
Generic
50742011808•Ingenus Pharmaceuticals LLC
$1.4361
per EA
CABERGOLINE 0.5 MG TABLET
Generic
69238269301•Amneal Pharmaceuticals NY LLC
$1.4361
per EA
CABERGOLINE 0.5 MG TABLET
Generic
70069082408•Somerset Therapeutics, LLC
$1.4361
per EA
BROMOCRIPTINE 2.5 MG TABLET
Generic
00781532501•Sandoz Inc.
$1.5691
per EA
BROMOCRIPTINE 2.5 MG TABLET
Generic
00781532531•Sandoz Inc.
$1.6800
per EA
BROMOCRIPTINE 2.5 MG TABLET
Generic
00574010601•Padagis US LLC
$1.6927
per EA
BROMOCRIPTINE 2.5 MG TABLET
Generic
00574010603•Padagis US LLC
$1.6927
per EA
BROMOCRIPTINE 2.5 MG TABLET
Generic
70954097810•ANI Pharmaceuticals, Inc.
$1.6927
per EA